You can stream this interview below, or click on the ‘Access Private Podcast' button to subscribe to our dedicated GP podcast.
In this episode we discuss the latest updates on PBS restrictions for type 2 diabetes medications. On 1st December 2024, a significant change was introduced which marks a pivotal shift in treatment accessibility and strategy.
Join us as we explore the implications of this change for clinical practice and discuss how it may transform the management of type 2 diabetes in Australia.
GP, Platinum Medical Centre, Chermside, Brisbane.
Deputy Director at The Baker Heart and Diabetes Institute, & Council member of Australian Diabetes Society.
GP Edition 163
Supported by: Supported by The Baker Heart and Diabetes Institute, in collaboration with AstraZeneca. Produced January 2025.
Tap the share icon
and select 'Add to Home Screen' to add the site to your home screen for quick access!